Hacker News Reader

I talked to the team, but unfortunately, jax-md at the ttime didn't do bond angles or torsions, so it wasn't good for biomolecular simulations.

My work mostly predated tensorflow and was much more about massive-scale embarassingly parallel computing, and produced some interesting large-scale results from MD and protein folding.

https://www.nature.com/articles/nchem.1821 https://onlinelibrary.wiley.com/doi/full/10.1002/pro.2389

View on HN

yup, i noticed that when i saw the first commits; in fact i thought it was someone's pet project. however, when i read that first odenet paper, it's clear keeping track of the gradients is extremely useful.

I'm very familiar with the first paper, the second author was on my committee.

so what does a cloud migration at a biotech company mean?

is it sort of a standard orchestrator + warehouse/lakehouse + distributed compute + cicd tools stack?

"is it sort of a standard orchestrator + warehouse/lakehouse + distributed compute + cicd tools stack?"

Ideally, yes, exactly. Except there are 100 orchestrators, 100 small local warehouses, and CI/CD is mostly jenkins.

Some things get forklifted over. I'm not trying to push people to adopt cloud native practices, just move them off physical onprem resources. Even that is a challenge because of data gravity.

Reply on news.ycombinator.com